EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

When Immunophenotype Is Not Identity: A Clinicopathological Review of Neuroendocrine Differentiation in Tumors of the Female Genital Tract

Catalin-Bogdan Satala, Alina-Mihaela Gurau, Gabriela Patrichi, Roxana-Cristina Mehedinti, Andy Radu Leibovici, Gabriela Gurau iD

Diagnostics · 21.05.2026 · 16 (10) · 1573

DOI: 10.3390/diagnostics16101573 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 21.05.2026. Verfasst von Catalin-Bogdan Satala und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, Medical and Pharmaceutical Research Center, "Dunarea de Jos" University of Galati, 800008 Galati, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine differentiation in tumors of the female genital tract is an uncommon but diagnostically consequential finding. Its interpretation is challenging because neuroendocrine marker expression does not necessarily define a neuroendocrine neoplasm. Focal or aberrant staining for synaptophysin, chromogranin A, CD56 or INSM1 may occur in otherwise conventional gynecologic carcinomas, whereas true poorly differentiated neuroendocrine carcinomas represent aggressive tumors with distinct prognostic and therapeutic implications. This narrative review examines neuroendocrine differentiation across the cervix, endometrium, ovary, vagina and vulva from an integrated clinicopathologic perspective. We emphasize that neuroendocrine differentiation should be approached as a diagnostic and biological spectrum, ranging from incidental immunophenotypic expression to carcinoma with neuroendocrine differentiation, mixed neuroendocrine/non-neuroendocrine tumors, well-differentiated neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas. Morphology remains the diagnostic anchor, while immunohistochemistry, molecular context and clinicoradiologic correlation refine classification and help exclude mimics or metastatic disease. Site-specific interpretation is essential: cervical neuroendocrine carcinoma is commonly HPV-associated and clinically aggressive; endometrial tumors require integration with p53, mismatch repair, POLE and SWI/SNF-related contexts; ovarian lesions demand distinction between primary well-differentiated neuroendocrine tumors, poorly differentiated carcinomas and metastases; and vaginal or vulvar tumors require careful exclusion of adjacent extension, cutaneous mimics and extragenital primaries. We propose a practical diagnostic framework that separates incidental marker expression from clinically meaningful neuroendocrine differentiation and links this distinction to reporting, prognosis and treatment. The central diagnostic question is not whether neuroendocrine markers are expressed but whether their expression defines a morphologically, biologically and clinically meaningful tumor category.

Schlagwörter

Stichwörter der Autor:innen

diagnostic pitfallsfemale genital tract tumorsgynecologic pathologyimmunohistochemistryimmunophenotypemixed neuroendocrine/non-neuroendocrine tumorsneuroendocrine carcinomaneuroendocrine differentiation

Autor:innen und Institutionen

  • Faculty of Medicine and Pharmacy, Medical and Pharmaceutical Research Center, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
  • Department of Pathology, Clinical County Emergency Hospital Braila, 810325 Braila, Romania.
  • The School for Doctoral Studies in Biomedical Sciences, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
  • The Doctoral School of Medicine and Pharmacy, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology, 540142 Targu Mures, Romania.
  • "Sf. Ioan" Clinical Emergency Pediatric Hospital, 800487 Galati, Romania.

ORCID-Profile: Gabriela Gurau

Zitieren

APA

Satala, C. B., Gurau, A. M., Patrichi, G., Mehedinti, R. C., Leibovici, A. R., & Gurau, G. (2026). When Immunophenotype Is Not Identity: A Clinicopathological Review of Neuroendocrine Differentiation in Tumors of the Female Genital Tract. Diagnostics, 16(10), 1573. https://doi.org/10.3390/diagnostics16101573

Vancouver

Satala CB, Gurau AM, Patrichi G, Mehedinti RC, Leibovici AR, Gurau G. When Immunophenotype Is Not Identity: A Clinicopathological Review of Neuroendocrine Differentiation in Tumors of the Female Genital Tract. Diagnostics. 2026;16(10):1573. doi:10.3390/diagnostics16101573

BibTeX
@article{Satala2026,
  author = {Satala, Catalin-Bogdan and Gurau, Alina-Mihaela and Patrichi, Gabriela and Mehedinti, Roxana-Cristina and Leibovici, Andy Radu and Gurau, Gabriela},
  title = {When Immunophenotype Is Not Identity: A Clinicopathological Review of Neuroendocrine Differentiation in Tumors of the Female Genital Tract},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {10},
  pages = {1573},
  doi = {10.3390/diagnostics16101573}
}
Kostenlos starten →